Ocular Therapeutix Inc
(NASDAQ : OCUL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-1.19%169.610.4%$366.40m
VRXValeant Pharmaceuticals International, Inc.
0.55%22.1514.1%$217.30m
PRGOPerrigo Co. Plc
0.48%76.226.7%$103.76m
JAZZJazz Pharmaceuticals Plc
1.52%167.512.2%$88.97m
PTLAPortola Pharmaceuticals, Inc.
0.95%41.367.7%$81.25m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.95%154.707.6%$75.53m
SAGESAGE Therapeutics, Inc.
-0.79%164.269.6%$72.52m
MNKMallinckrodt Plc
-2.30%15.7021.1%$56.10m
SUPNSupernus Pharmaceuticals, Inc.
-0.71%56.106.3%$48.46m
UTHRUnited Therapeutics Corporation
-1.33%106.2714.4%$40.29m
PBHPrestige Brands Holdings, Inc.
-2.03%34.303.8%$39.55m
ICPTIntercept Pharmaceuticals, Inc.
1.74%72.4521.8%$35.73m
CTLTCatalent Inc
1.87%40.232.6%$32.23m
HZNPHorizon Pharma plc
0.27%15.117.5%$29.77m
ENDPEndo International Plc
-1.61%6.108.9%$28.38m

Company Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its products include dextenza, sustained release travopost, and posterior segment injections. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.